(Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | (FY)Dec 31, 2019 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | -17.75%33.62B | 7.57%84.72B | 21.95%40.87B | 30.62%78.76B | 20.14%33.52B | 18.39%60.3B | 33.08%27.9B | 16.19%50.93B | 15.32%20.96B | 22.59%43.83B |
Operating income | -17.75%33.62B | 7.57%84.72B | 21.95%40.87B | 30.62%78.76B | 20.14%33.52B | 18.39%60.3B | 33.08%27.9B | 16.19%50.93B | 15.32%20.96B | 22.59%43.83B |
Cost of sales | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -22.31%-34.2B |
Operating expenses | 18.16%-25.47B | -5.76%-63.39B | -22.29%-31.13B | -25.91%-59.93B | -16.33%-25.45B | -17.54%-47.6B | -31.43%-21.88B | -18.41%-40.5B | -16.58%-16.65B | -22.31%-34.2B |
Gross profit | -16.45%8.14B | 13.33%21.34B | 20.90%9.75B | 48.28%18.83B | 34.00%8.06B | 21.69%12.7B | 39.43%6.02B | 8.33%10.43B | 10.68%4.31B | 23.59%9.63B |
Selling expenses | 9.82%-426.12M | -19.47%-1.11B | -17.72%-472.51M | -34.84%-928.26M | -27.58%-401.39M | -8.33%-688.39M | -37.99%-314.63M | 8.22%-635.47M | 21.21%-228M | -3.31%-692.38M |
Administrative expenses | 11.35%-2.16B | -5.23%-5.65B | -9.59%-2.43B | -49.30%-5.37B | -49.72%-2.22B | -15.08%-3.59B | -13.75%-1.48B | 48.83%-3.12B | 38.30%-1.3B | -34.77%-6.1B |
Research and development expenses | 20.36%-2.03B | -26.29%-7.57B | -26.75%-2.55B | -73.70%-6B | -49.34%-2.01B | -15.00%-3.45B | -44.64%-1.35B | ---3B | ---931.58M | ---- |
Profit from asset sales | 273.46%3.4M | -78.03%30.89M | -66.02%910.68K | 84.32%140.63M | 5,050.12%2.68M | -36.42%76.3M | -2.37%52.04K | --120M | --53.3K | ---- |
Revaluation surplus | 40.94%-4.8M | -167.50%-18.85M | -252.89%-8.13M | -240.24%-7.05M | 112.67%5.31M | -97.28%5.02M | -199.89%-41.94M | --184.73M | --41.99M | ---- |
-Changes in the fair value of other assets | 40.94%-4.8M | -167.50%-18.85M | -252.89%-8.13M | -240.24%-7.05M | 112.67%5.31M | -97.28%5.02M | -199.89%-41.94M | --184.73M | --41.99M | ---- |
Impairment and provision | 37.26%-212.15M | 23.98%-826.55M | 7.63%-338.16M | -374.34%-1.09B | -51.41%-366.1M | -33.15%-229.22M | -11.40%-241.79M | 38.89%-172.15M | -145.80%-217.04M | -81.42%-281.72M |
-Other impairment is provision | 37.26%-212.15M | 23.98%-826.55M | 7.63%-338.16M | -374.34%-1.09B | -51.41%-366.1M | -33.15%-229.22M | -11.40%-241.79M | 38.89%-172.15M | -145.80%-217.04M | -81.42%-281.72M |
Special items of operating profit | 28.95%532.4M | 16.71%1.13B | 5.88%412.88M | 28.74%965.18M | 28.55%389.96M | -5.14%749.72M | 64.79%303.35M | 25.98%790.38M | 23.88%184.08M | -3.55%627.37M |
Operating profit | -11.82%3.64B | 12.23%6.84B | 22.98%4.13B | 12.33%6.1B | 18.58%3.36B | 20.96%5.43B | 56.55%2.83B | 41.02%4.49B | 16.11%1.81B | 2.98%3.18B |
Financing income | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 109.35%412.68M |
Financing cost | -49.98%75.47M | 66.00%146.65M | 0.40%150.87M | 153.49%88.34M | 321.09%150.27M | 22.81%-165.15M | -414.00%-67.97M | 69.03%-213.96M | 107.04%21.65M | -14.86%-690.88M |
Share of profits of associates | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 12.20%209.76M |
Share of profit from joint venture company | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -26.76%18.91M |
Special items of earning before tax | -54.19%15.06M | 39.60%79.63M | 52.25%32.88M | 8.50%57.04M | 6.42%21.6M | 1,294.72%52.58M | 1,375.82%20.3M | ---4.4M | --1.38M | ---- |
Earning before tax | -13.48%3.73B | 13.24%7.07B | 22.19%4.31B | 17.45%6.24B | 26.79%3.53B | 24.51%5.31B | 51.98%2.78B | 36.28%4.27B | 25.74%1.83B | 8.08%3.13B |
Tax | 6.98%-339.24M | -3.03%-380.33M | 3.47%-364.71M | 23.10%-369.14M | -11.18%-377.84M | -2.08%-480M | -61.56%-339.84M | -41.28%-470.23M | -33.63%-210.35M | -3.12%-332.82M |
After-tax profit from continuing operations | -14.08%3.39B | 13.89%6.69B | 25.27%3.95B | 21.47%5.87B | 28.96%3.15B | 27.29%4.83B | 50.74%2.44B | 35.68%3.8B | 24.78%1.62B | 8.70%2.8B |
Earning after tax | -14.08%3.39B | 13.89%6.69B | 25.27%3.95B | 21.47%5.87B | 28.96%3.15B | 27.29%4.83B | 50.74%2.44B | 35.68%3.8B | 24.78%1.62B | 8.70%2.8B |
Minority profit | -10.99%2.14B | 19.39%4.24B | 24.33%2.4B | 44.09%3.55B | 55.45%1.93B | 32.19%2.47B | 63.12%1.24B | 28.44%1.87B | 15.44%762.33M | 12.60%1.45B |
Profit attributable to shareholders | -18.89%1.25B | 5.45%2.45B | 26.77%1.54B | -2.06%2.32B | 1.49%1.22B | 22.57%2.37B | 39.74%1.2B | 43.49%1.93B | 34.45%858.13M | 4.79%1.35B |
Basic earnings per share | -21.11%0.157 | 3.32%0.311 | 25.95%0.199 | -1.95%0.301 | 1.28%0.158 | 22.80%0.307 | 41.82%0.156 | 43.68%0.25 | 7.63%0.11 | -19.07%0.174 |
Diluted earnings per share | -21.11%0.157 | 3.32%0.311 | 25.95%0.199 | -1.95%0.301 | 1.28%0.158 | 22.80%0.307 | 41.82%0.156 | 43.68%0.25 | 7.63%0.11 | -19.07%0.174 |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | IAS |
Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
Auditor | -- | Dahua Certified Public Accountants (Special General Partnership) | -- | Dahua Certified Public Accountants (Special General Partnership) | -- | Nobunaga Zhonghe (Hong Kong) Certified Public Accountants Limited | -- | Nobunaga Zhonghe (Hong Kong) Certified Public Accountants Limited | -- | Xinyong Zhonghe (Hong Kong) Certified Public Accountants Limited, Xinyong Zhonghe Certified Public Accountants (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data